Drug,Pharmacological class,Interacting Drug or Class,Rationale,Recommendation,Quality of Evidence,Strength of Recommendation
Enalapril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Lisinopril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Captopril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Benazepril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Fosinopril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Moexipril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Perindopril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Quinapril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Ramipril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Trandolapril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Imidapril,Angiotensin converting enzyme inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Valsartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Losartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Azilsartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Candesartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Irbesartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Olmesartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Telmisartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Eprosartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Fimasartan,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Sacubitril/valsartan,Angiotensin receptor neprilysin inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Aliskiren,Renin inhibitors,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Amiloride,Potassium-sparing diuretics,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Triamterene,Potassium-sparing diuretics,Another RAS inhibitor or a potassium-sparing diuretic,Increased risk of hyperkalemia,"Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium-sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher.",Moderate,Strong
Morphine,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Methadone,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Oxycodone,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Hydrocodone,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Fentanyl,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Codeine,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Tramadol,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Oxymorphone,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Buprenorphine,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Meperidine,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Pethidine,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Hydromorphone,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Tapentadol,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Remifentanil,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Alfentanil,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Pentazocine,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Sufentanil,Opioids,Benzodiazepines,Increased risk of overdose and adverse events,Avoid,Moderate,Strong
Morphine,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Methadone,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Oxycodone,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Hydrocodone,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Fentanyl,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Codeine,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Tramadol,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Oxymorphone,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Buprenorphine,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Meperidine,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Pethidine,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Hydromorphone,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Tapentadol,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Remifentanil,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Alfentanil,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Pentazocine,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Sufentanil,Opioids,Gabapentin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Morphine,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Methadone,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Oxycodone,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Hydrocodone,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Fentanyl,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Codeine,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Tramadol,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Oxymorphone,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Buprenorphine,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Meperidine,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Pethidine,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Hydromorphone,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Tapentadol,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Remifentanil,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Alfentanil,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Pentazocine,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Sufentanil,Opioids,Pregabalin,"Increased risk of severe sedation-related adverse events, including respiratory depression and death.","Avoid; exceptions are when transitioning from opioid therapy to gabapentin or pregablin, or when using gabapentinoids to reduce opioid dose, although caution should be used in all circumstances.",Moderate,Strong
Amitriptyline,Tricyclic antidepressants,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Amoxapine,Tricyclic antidepressants,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Clomipramine,Tricyclic antidepressants,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Desipramine,Tricyclic antidepressants,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Doxepin,Tricyclic antidepressants,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid >6mg/day; minimize the number of anticholinergic drugs.,Moderate,Strong
Imipramine,Tricyclic antidepressants,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Nortriptyline,Tricyclic antidepressants,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Paroxetine,Selective serotonin re-uptake inhibitors,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Prochlorperazine,Antiemetics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Promethazine,"Antiemetics, First-generation antihistamines",Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Brompheniramine,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Chlorpheniramine,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Cyproheptadine,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Dimenhydrinate,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Diphenhydramine,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Doxylamine,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Hydroxyzine,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Meclizine,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Triprolidine,First-generation antihistamines,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Darifenacin,Antimuscarinics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Fesoterodine,Antimuscarinics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Flavoxate,Antimuscarinics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Oxybutynin,Antimuscarinics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Solifenacin,Antimuscarinics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Tolterodine,Antimuscarinics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Trospium,Antimuscarinics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Benztropine,Antiparkinsonian agents ,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Trihexyphenidyl,Antiparkinsonian agents ,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Chlorpromazine,Antipsychotics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Clozapine,Antipsychotics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Olanzapine,Antipsychotics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Perphenazine,Antipsychotics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Atropine,Antispasmodics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Clidinium/chlordiazepoxide,Antispasmodics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Dicyclomine,Antispasmodics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Homatropine,Antispasmodics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Hyoscyamine,Antispasmodics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Scopolamine,Antispasmodics,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Cyclobenzaprine,Skeletal muscle relaxants ,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Orphenadrine,Skeletal muscle relaxants ,Anticholinergics,"Use of more than one medication with anticholinergic properties increases the risk of cognitive decline, delirium, and falls or fractures.",Avoid; minimize the number of anticholinergic drugs.,Moderate,Strong
Carbamazepine,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Phenytoin,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Valproate,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Valproic acid,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Phenobarbitone,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Perampanel,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Levetiracetam,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Topiramate,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Lamotrigine,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Zonisamide,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Lacosamide,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Eslicarbazepine,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Rufinamide,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Cannabidiol ,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Gabapentin,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Pregabalin,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Oxcarbazepine,Antiepileptics,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Duloxetine,Serotonin and norepinephrine reuptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Venlafaxine,Serotonin and norepinephrine reuptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Desvenlafaxine,Serotonin and norepinephrine reuptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Escitalopram,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Fluoxetine,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Fluvoxamine,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Paroxetine,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Sertraline,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Vortioxetine,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Citalopram,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Dapoxetine,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Trazodone,Selective serotonin re-uptake inhibitors,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Amitriptyline,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Clomipramine,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Dothiepin,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Dosulepin,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Imipramine,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Nortriptyline,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Doxepin,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Amoxapine,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Desipramine,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Protriptyline,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Tianeptine,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Trimipramine,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Melitracen,Tricyclic antidepressants,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Aripiprazole,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Olanzapine,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Perphenazine,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Quetiapine,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Risperidone,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Chlorpromazine,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Clozapine,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Haloperidol,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Paliperidone,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Lurasidone,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Ziprasidone,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Fluphenazine,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Brexpiprazole,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Cariprazine,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Pimavanserin,Antipsychotics ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Alprazolam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Chlordiazepoxide ,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Applicable to chlordiazepoxide alone/ in combination with amitriptyline or clidinium:
Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Clobazam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Clonazepam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Clorazepate,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Diazepam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Estazolam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Lorazepam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Midazolam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Oxazepam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Temazepam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Triazolam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Flurazepam,Benzodiazepines,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Zolpidem,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ",Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Zaleplon,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ",Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Eszopiclone,"Nonbenzodiazepine benzodiazepine receptor agonist hypnotics (""Z-drugs"") ",Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Morphine,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Methadone,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Oxycodone,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Hydrocodone,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Fentanyl,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Codeine,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Tramadol,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Oxymorphone,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Buprenorphine,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Meperidine,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Pethidine,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Hydromorphone,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Tapentadol,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Remifentanil,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Alfentanil,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Pentazocine,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Sufentanil,Opioids,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Carisoprodol,Skeletal muscle relaxants ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Chlorzoxazone,Skeletal muscle relaxants ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Cyclobenzaprine,Skeletal muscle relaxants ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Metaxalone,Skeletal muscle relaxants ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Methocarbamol,Skeletal muscle relaxants ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Orphenadrine,Skeletal muscle relaxants ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Baclofen,Skeletal muscle relaxants ,Any combination of >=3 of these CNS-active drugs.,"Increased risk of falls and of fracture with the concurrent use of >=3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).","Avoid concurrent use of >=3 CNS-active drugs (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants); minimize the number of CNS-active drugs.",High,Strong
Lithium,Antimanic agents,Angiotensin converting enzyme inhibitors,Increased risk of lithium toxicity.,Avoid; monitor lithium concentrations,Moderate,Strong
Lithium,Antimanic agents,Angiotensin II subtype 1 receptor blockers; Angiotensin II receptor type 1 receptor blockers,Increased risk of lithium toxicity.,Avoid; monitor lithium concentrations,Moderate,Strong
Lithium,Antimanic agents,Angiotensin receptor neprilysin inhibitors,Increased risk of lithium toxicity.,Avoid; monitor lithium concentrations,Moderate,Strong
Lithium,Antimanic agents,Loop diuretics,Increased risk of lithium toxicity.,Avoid; monitor lithium concentrations,Moderate,Strong
Doxazosin,Non-selective peripheral alpha-1 blockers ,Loop diuretics,Increased risk of urinary incontinence in older women.,"Avoid in older women, unless conditions warrant both drugs.",Moderate,Strong
Prazosin,Non-selective peripheral alpha-1 blockers ,Loop diuretics,Increased risk of urinary incontinence in older women.,"Avoid in older women, unless conditions warrant both drugs.",Moderate,Strong
Terazosin,Non-selective peripheral alpha-1 blockers ,Loop diuretics,Increased risk of urinary incontinence in older women.,"Avoid in older women, unless conditions warrant both drugs.",Moderate,Strong
Tamsulosin,Selective peripheral alpha-1 blockers,Loop diuretics,"Increased risk of urinary incontinence in older women.

Data are limited for selective peripheral alpha-1 blockers (e.g., tamsulosin, silodosin, and others) but may apply as well.","Avoid in older women, unless conditions warrant both drugs.",Moderate,Strong
Silodosin,Selective peripheral alpha-1 blockers,Loop diuretics,"Increased risk of urinary incontinence in older women.

Data are limited for selective peripheral alpha-1 blockers (e.g., tamsulosin, silodosin, and others) but may apply as well.","Avoid in older women, unless conditions warrant both drugs.",Moderate,Strong
Alfuzosin,Selective peripheral alpha-1 blockers,Loop diuretics,"Increased risk of urinary incontinence in older women.

Data are limited for selective peripheral alpha-1 blockers (e.g., tamsulosin, silodosin, and others) but may apply as well.","Avoid in older women, unless conditions warrant both drugs.",Moderate,Strong
Phenytoin,Antiepileptics  ,Trimethoprim/sulfamethoxazole,Increased risk of phenytoin toxicity.,Avoid,Moderate,Strong
Theophylline,Xanthines,Cimetidine,Increased risk of theophylline toxicity.,Avoid,Moderate,Strong
Theophylline,Xanthines,Ciprofloxacin,Increased risk of theophylline toxicity.,Avoid,Moderate,Strong
Warfarin,Vitamin K antagonists,Amiodarone,Increased risk of bleeding.,"Avoid when possible; if used together, monitor INR closely.",Moderate,Strong
Warfarin,Vitamin K antagonists,Ciprofloxacin,Increased risk of bleeding.,"Avoid when possible; if used together, monitor INR closely.",Moderate,Strong
Warfarin,Vitamin K antagonists,Macrolide antibiotics (excluding azithromycin),Increased risk of bleeding.,"Avoid when possible; if used together, monitor INR closely.",Moderate,Strong
Warfarin,Vitamin K antagonists,Trimethoprim/sulfamethoxazole,Increased risk of bleeding.,"Avoid when possible; if used together, monitor INR closely.",Moderate,Strong
Warfarin,Vitamin K antagonists,Selective serotonin re-uptake inhibitors,Increased risk of bleeding.,"Avoid when possible; if used together, monitor INR closely.",Moderate,Strong
